Furthermore, BCL-3 appears to still modulate β-catenin/TCF-mediated transcription downstream of mutated APC (SW1463, SW620) and β-catenin (LS174T), two of the most frequent mutations in CRC (Cancer Genome Atlas Network, 2012). The gene discussed is HNF4A; the disease is colorectal carcinoma.